Integra Lifesciences Holdings (IART) Current Assets (2016 - 2026)
Integra Lifesciences Holdings' Current Assets history spans 17 years, with the latest figure at $1.2 billion for Q4 2025.
- On a quarterly basis, Current Assets rose 7.2% to $1.2 billion in Q4 2025 year-over-year; TTM through Dec 2025 was $1.2 billion, a 7.2% increase, with the full-year FY2025 number at $1.2 billion, up 7.2% from a year prior.
- Current Assets hit $1.2 billion in Q4 2025 for Integra Lifesciences Holdings, up from $1.1 billion in the prior quarter.
- Over the last five years, Current Assets for IART hit a ceiling of $1.4 billion in Q1 2024 and a floor of $1.0 billion in Q3 2023.
- Historically, Current Assets has averaged $1.1 billion across 5 years, with a median of $1.1 billion in 2021.
- Biggest five-year swings in Current Assets: surged 37.51% in 2024 and later fell 21.79% in 2025.
- Tracing IART's Current Assets over 5 years: stood at $1.2 billion in 2021, then rose by 0.67% to $1.2 billion in 2022, then decreased by 8.91% to $1.1 billion in 2023, then increased by 2.23% to $1.1 billion in 2024, then rose by 7.2% to $1.2 billion in 2025.
- Business Quant data shows Current Assets for IART at $1.2 billion in Q4 2025, $1.1 billion in Q3 2025, and $1.1 billion in Q2 2025.